GH / Body CompositionCJC-1295 / Ipamorelin
10 mg · Lyophilized Powder
Two-peptide blend for growth-hormone signalling research.
Batch COA available by email on request
Published areas of interest.
This page summarises published research areas for general information. It does not establish safety, efficacy, or suitability for any use.
CJC-1295 and ipamorelin are two separate peptides studied in relation to growth-hormone signalling. The available human evidence examines the components separately, not this exact blend.
Areas of research interest
Current evidence
Early human studies measured hormone concentrations and pharmacology for each component separately. Preclinical ipamorelin research also includes cells and animals. No direct peer-reviewed clinical evidence for the exact combination was identified.
Important limitations
The studies were early-stage, short and focused on surrogate hormone measurements. Results for either component cannot be extrapolated to the blend, and long-term safety or clinical effectiveness has not been established.
Documentation for this material.
Janoshik Certificate of Analysis available by email. Contact us with the product name and batch number.
Understand our testingFor research use only.
Not for human or animal consumption. Not an approved therapeutic good. The TGA identifies CJC-1295 / Ipamorelin as an unapproved therapeutic good in Australia.